PLOS Neglected Tropical Diseases: The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
![Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons - Kavishe - 2017 - The FEBS Journal - Wiley Online Library Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons - Kavishe - 2017 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/286171d4-447a-40a8-9cc0-1a6c8607b5a1/febs14097-toc-0001-m.jpg)
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons - Kavishe - 2017 - The FEBS Journal - Wiley Online Library
![Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum - ScienceDirect Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535947620350817-gr9.jpg)
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum - ScienceDirect
![Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic | Nature Medicine Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnm.4381/MediaObjects/41591_2017_Article_BFnm4381_Fig1_HTML.jpg)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic | Nature Medicine
![References in Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial - The Lancet Infectious Diseases References in Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2001017322/2003841837/gr1.gif)
References in Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial - The Lancet Infectious Diseases
![Frontiers | The Knockout for G Protein-Coupled Receptor-Like PfSR25 Increases the Susceptibility of Malaria Parasites to the Antimalarials Lumefantrine and Piperaquine but Not to Medicine for Malaria Venture Compounds | Microbiology Frontiers | The Knockout for G Protein-Coupled Receptor-Like PfSR25 Increases the Susceptibility of Malaria Parasites to the Antimalarials Lumefantrine and Piperaquine but Not to Medicine for Malaria Venture Compounds | Microbiology](https://www.frontiersin.org/files/Articles/638869/fmicb-12-638869-HTML/image_m/fmicb-12-638869-g001.jpg)